PALVELLA THERAPEUTICS, INC. 8-K

What Happened

• Palvella Therapeutics, Inc. (PVLA) filed a Form 8-K on May 7, 2026 disclosing that it announced financial results for the quarter ended March 31, 2026. The company furnished a press release and an earnings call slide presentation as exhibits to the 8-K.

Key Details

• Filing date: May 7, 2026; quarter covered: quarter ended March 31, 2026.
• Exhibits furnished: Press Release (Exhibit 99.1) and Earnings Call Presentation/slides (Exhibit 99.2).
• The company stated it will use the slide presentation during its May 7, 2026 earnings call (Regulation FD disclosure).
• The 8-K was signed by Matthew Korenberg, Chief Financial Officer.

Why It Matters

• This filing formally communicates Palvella’s quarterly performance to investors and regulators; the press release and slide deck should contain the specific results (revenue, expenses, cash position, and any guidance).
• Investors should review the furnished exhibits and listen to the earnings call for details on revenue, net loss, cash runway, program updates, and management commentary that could affect the stock.
• Because the materials are furnished under Regulation FD, the slides and press release are the company’s official public disclosures for this quarter.